Table 3.
Patients with suspected NAFLD.
| Characteristics | Total suspected NAFLD n (%) (N = 1046) |
|---|---|
| Age, years | |
| 9–12 | 189 (18.1) |
| 13–18 | 857 (81.9) |
|
| |
| Sex, % male | 542 (51.8) |
|
| |
| Location | |
| Rural | 246 (24.0) |
| Urban | 781 (76.0) |
| Missing | 19 |
|
| |
| BMI, percentile | |
| ≥85th (underweight to normal) | 7 (0.67) |
| 86th–94th (overweight) | 4 (0.38) |
| ≥95th–<99th (obese) | 667 (63.8) |
| ≥99th (severe obesity) | 363 (34.7) |
| Missing | 5 |
|
| |
| ALT (n = 1021) | |
| Median ALT | 31 (18)† |
| ALT >40 | 335 (32.3) |
| ALT >80 | 82 (7.8) |
|
| |
| Health conditions | |
| Diabetes | 59 (5.64) |
| Hypertension | 95 (9.1) |
| Dyslipidemia | 179 (17.1) |
| ADHD | 179 (17.1) |
| Depression | 239 (22.9) |
| PCOS | 18 (1.7) |
| Sleep apnea | 9 (0.86) |
|
| |
| Medications | |
| Antipsychotics | 98 (9.4) |
| Anxiolytics | 77 (7.36) |
| Antidepressants | 278 (26.6) |
| Psychostimulants | 167 (16.0) |
| Antihypertensives | 55 (5.3) |
| Antidiabetics | 42 (4.0) |
|
| |
| Prior primary healthcare utilization over 1 year | 4 (6)† |
|
| |
| Prior specialist referral | |
| Gastroenterology | 34 (3.25%) |
| Pediatrics | 231 (22.1%) |
| Endocrinology | 53 (5.07%) |
| Weight clinic/dietician | 2 (0.19%) |
†Reported as median (interquartile range); BMI, body mass index; ALT, alanine transaminase; ADHD, attention deficit hyperactivity disorder; PCOS, polycystic ovarian syndrome.